770
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity

, , , , , , , & show all
Pages 1078-1087 | Accepted 25 Apr 2012, Published online: 14 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Regina Grebla, Juliana Setyawan, Chanhyun Park, Kristin M. Richards, Esmond D. Nwokeji, Manjiri Pawaskar, M. Haim Erder & Kenneth A. Lawson. (2019) Examining the heterogeneity of treatment patterns in attention deficit hyperactivity disorder among children and adolescents in the Texas Medicaid population: modeling suboptimal treatment response. Journal of Medical Economics 22:8, pages 788-797.
Read now
Paul Hodgkins, Ralf W Dittmann, Shaw Sorooshian & Tobias Banaschewski. (2013) Individual treatment response in attention-deficit/hyperactivity disorder: broadening perspectives and improving assessments. Expert Review of Neurotherapeutics 13:4, pages 425-433.
Read now

Articles from other publishers (3)

Kenneth B. Gordon, Keith A. Betts, Murali Sundaram, James E. Signorovitch, Junlong Li, Meng Xie, Eric Q. Wu & Martin M. Okun. (2017) Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials. Journal of the American Academy of Dermatology 77:6, pages 1030-1037.
Crossref
Ayaka Ishii-Takahashi, Ryu Takizawa, Yukika Nishimura, Yuki Kawakubo, Kasumi Hamada, Shiho Okuhata, Shingo Kawasaki, Hitoshi Kuwabara, Takafumi Shimada, Ayako Todokoro, Takashi Igarashi, Kei-ichiro Watanabe, Hidenori Yamasue, Nobumasa Kato, Kiyoto Kasai & Yukiko Kano. (2015) Neuroimaging-Aided Prediction of the Effect of Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder: A Randomized Controlled Trial. Neuropsychopharmacology 40:12, pages 2676-2685.
Crossref
Juliana Setyawan, Hongbo Yang, David Cheng, Xiaopeng Cai, James Signorovitch, Jipan Xie & M. Haim Erder. (2015) Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder. Value in Health 18:6, pages 824-831.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.